Latest Finepoint Capital LP Stock Portfolio
Finepoint Capital LP Performance:
2025 Q3: -10.61%YTD: 30.77%2024: -3.78%
Performance for 2025 Q3 is -10.61%, and YTD is 30.77%, and 2024 is -3.78%.
About Finepoint Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Finepoint Capital LP reported an equity portfolio of $1.7 Billions as of 30 Sep, 2025.
The top stock holdings of Finepoint Capital LP are SSNT, , SLDB. The fund has invested 24.4% of it's portfolio in QXO INC and 6.4% of portfolio in RXO INC.
The fund managers got completely rid off LIBERTY MEDIA CORP DEL (BATRA), LAKESHORE BIOPHARMA CO LTD and CALIDI BIOTHERAPEUTICS INC (FLAG) stocks. Finepoint Capital LP opened new stock positions in RXO INC and CALIDI BIOTHERAPEUTICS INC (FLAG). The fund showed a lot of confidence in some stocks as they added substantially to QXO INC (SSNT).
The top stock holdings of Finepoint Capital LP are SSNT, , SLDB. The fund has invested 24.4% of it's portfolio in QXO INC and 6.4% of portfolio in RXO INC.
The fund managers got completely rid off LIBERTY MEDIA CORP DEL (BATRA), LAKESHORE BIOPHARMA CO LTD and CALIDI BIOTHERAPEUTICS INC (FLAG) stocks. Finepoint Capital LP opened new stock positions in RXO INC and CALIDI BIOTHERAPEUTICS INC (FLAG). The fund showed a lot of confidence in some stocks as they added substantially to QXO INC (SSNT).
Finepoint Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that Finepoint Capital LP made a return of -10.61% in the last quarter. In trailing 12 months, it's portfolio return was 28.97%.
New Buys
| Ticker | $ Bought |
|---|---|
| rxo inc | 111,764,000 |
| calidi biotherapeutics inc | 1,584 |
New stocks bought by Finepoint Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| qxo inc | 5.4 |
Additions to existing portfolio by Finepoint Capital LP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| liberty media corp del | -43,587,100 |
| lakeshore biopharma co ltd | -19,551 |
| calidi biotherapeutics inc | -2,875 |
Finepoint Capital LP got rid off the above stocks
Sector Distribution
Finepoint Capital LP has about 78.3% of it's holdings in Technology sector.
| Sector | % |
|---|---|
| Technology | 78.3 |
| Others | 20.6 |
| Healthcare | 1.1 |
Market Cap. Distribution
Finepoint Capital LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 78.3 |
| UNALLOCATED | 20.6 |
| SMALL-CAP | 1.1 |
Stocks belong to which Index?
About 0% of the stocks held by Finepoint Capital LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
Finepoint Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Finepoint Capital LP
Finepoint Capital LP has 7 stocks in it's portfolio. SSNT proved to be the most loss making stock for the portfolio. SLDB was the most profitable stock for Finepoint Capital LP last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| BATRA | liberty media corp del | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FLAG | calidi biotherapeutics inc | 0.00 | 1,042 | 1,584 | new | |||
| FLAG | calidi biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SLDB | solid biosciences inc | 0.34 | 961,251 | 5,930,920 | unchanged | 0.00 | ||
| SSNT | qxo inc | 24.44 | 22,295,600 | 424,954,000 | added | 5.4 | ||
| rxo inc | 6.43 | 7,266,840 | 111,764,000 | new | ||||
| aleanna inc | 0.01 | 27,717 | 115,857 | unchanged | 0.00 | |||
| aleanna inc | 0.01 | 490,000 | 111,720 | unchanged | 0.00 | |||
| moneyhero ltd | 0.01 | 895,000 | 99,972 | unchanged | 0.00 | |||
| lakeshore biopharma co ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | |||